Gloria Ines I. G. C.
- Country
- Spain
- Department
- Hematology service
Research Overview
- Open-label dose-finding and dose-expansion study to evaluate the safety, expansion, persistence, and clinical activity of UCART20x22 in subjects with relapsed or refractory B-cell Non-Hodgkin Lymphoma (B-NHL)
- Phase 1b/2 Study of MK-1045 Monotherapy and MK-1045 Plus Tocilizumab in Adults with Relapsed/Refractory Non‑Hodgkin Lymphoma
- Phase 2/3 Randomized Open‑Label Study of MK‑1045 Combined with Rituximab Versus Standard Chemotherapy Plus Rituximab in First‑Line Follicular Lymphoma
Data & Insights
Has run more than one trial at 81 of 217 partner sites.
Specializations
Thoracic Oncology
The investigator is involved in clinical research across non-small cell lung cancer, small cell lung cancer, and other advanced thoracic malignancies, with attention to both locally advanced and metastatic disease. The portfolio also includes biomarker-defined lung cancer populations and treatment settings spanning resectable and unresectable disease.
- Non-small cell lung cancer
- Small cell lung cancer
- Advanced thoracic malignancies
- Biomarker-selected lung cancer
Research activity in this area reflects a strong focus on targeted and immune-based strategies for lung cancer and related thoracic tumors.
Breast and Gynecologic Cancers
Clinical work includes breast cancer subtypes such as HER2-positive, HER2-negative, and triple-negative breast cancer, as well as ovarian cancer, endometrial cancer, and cervical cancer. The research landscape extends to recurrent, metastatic, and high-risk disease across the female solid tumor spectrum.
- Breast cancer
- Triple-negative breast cancer
- Ovarian cancer
- Endometrial cancer
This area is closely linked to studies of receptor-defined disease and advanced gynecologic malignancies.
Hematologic Malignancies
The investigator participates in trials involving acute myeloid leukemia, myelodysplastic syndromes, chronic lymphocytic leukemia, and multiple non-Hodgkin lymphoma subtypes, including diffuse large B-cell lymphoma and mantle cell lymphoma. The portfolio also reaches relapsed and refractory blood cancers and transplant-related hematologic complications.
- Acute myeloid leukemia
- Myelodysplastic syndromes
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
Research in this domain includes malignancies with unmet treatment needs and molecularly defined hematologic disease.
Renal, Urologic, and Hepatobiliary Disease
Clinical interests include renal cell carcinoma, urothelial carcinoma, prostate cancer, and hepatocellular carcinoma, along with broader biliary tract cancer and pancreatic tumor research. The investigator is also involved in kidney-related conditions such as kidney transplantation and immune-mediated renal disease.
- Renal cell carcinoma
- Urothelial carcinoma
- Prostate cancer
- Hepatocellular carcinoma
This research area connects solid tumor oncology with organ-specific disease management and transplant-associated care.
Immune-Mediated and Systemic Disorders
The investigator is also active in trials for systemic lupus erythematosus, rheumatoid arthritis, myasthenia gravis, asthma, and inflammatory bowel disease. Additional interests include interstitial lung disease, amyloidosis, and other chronic immune-driven conditions.
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Myasthenia gravis
- Asthma
These studies broaden the therapeutic scope beyond oncology into autoimmune, respiratory, and multisystem inflammatory disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.